Skip to main content
. 2020 Dec 11;22(7):1161–1175. doi: 10.1002/cbic.202000647

Table 1.

Summary of the mutations to the six conserved histidines: effects on PPOs′ copper content and diphenolase/monophenolase activity. The modification of copper content and the activities′ rate are described compared to the wild type of the corresponding enzymes.

Conserved histidines

Enzyme

Mutant

Diphenolase activity

Monophenolase activity

Copper %

Ref.

CgAUS

His93Ala (HisA1)

−178‐fold (butein: 62 μmol/(l×min) −240‐fold (fisetin: 92 μmol/(l×min) −575‐fold (4‐tert‐butylcatechol: 218 μmol/(l×min)

n.i.

50

[53]

His116Ala‐(HisA2)

n.d. (butein, fisetin, and 4‐tert‐butylcatechol)

n.i.

50

His125Ala‐(HisA3)

n.d. (butein, fisetin, and 4‐tert‐butylcatechol)

n.i.

50

His252Ala‐(HisB1)

n.d. (butein, fisetin, and 4‐tert‐butylcatechol)

n.i.

n.i.

His256Ala‐(HisB2)

−409‐fold (butein: 27 μmol/(l×min) n.d. (fisetin and 4‐tert‐butylcatechol)

n.i.

n.i.

His286Ala‐(HisB3)

n.d. (butein, fisetin, and 4‐tert‐butylcatechol)

n.i.

n.i.

HsTYR

His363Ala‐(HisB1)

n.i.

n.d. (l‐tyrosine)

0

[54]

His367Ala‐(HisB2)

n.i.

n.d. (l‐tyrosine)

50

His390Ala‐(HisB3)

n.i.

n.d. (l‐tyrosine)

250

His180Ala‐(HisA1)

−1.20‐fold (l‐DOPA: 28.5 s−1)

−1.79‐fold (l‐tyrosine: 0.34 s−1)

n.i.

[55]

His202Ala‐(HisA2)

−1.14‐fold (l‐DOPA: 30.0 s−1)

−1.45‐fold (l‐tyrosine: 0.42 s−1)

n.i.

His211Ala‐(HisA3)

−1.05‐fold (l‐DOPA: 32.4 s−1)

−1.22‐fold (l‐tyrosine: 0.50 s−1)

n.i.

His363Ala‐(HisB1)

−1.98‐fold (l‐DOPA: 17.2 s−1)

−1.38‐fold (l‐tyrosine: 0.44 s−1)

n.i.

His367Ala‐(HisB2)

−2.16‐fold (l‐DOPA: 15.8 s−1)

−1.27‐fold (l‐tyrosine: 0.48 s−1)

n.i.

His390Ala‐(HisB3)

−1.15‐fold (l‐DOPA: 29.7 s−1)

−1.17‐fold (l‐tyrosine: 0.52 s−1)

n.i.

AoTYR[a]

His63Asn‐(HisA1)

n.d. (l‐DOPA)

n.d. (l‐tyrosine)

45

[56]

His84Asn‐(HisA2)

n.d. (l‐DOPA)

n.d. (l‐tyrosine)

35

His93Asn‐(HisA3)

n.d. (l‐DOPA)

n.d. (l‐tyrosine)

50

His290Asn‐(HisB1)

n.d. (l‐DOPA)

n.d. (l‐tyrosine)

30

His294Asn‐(HisB2)

n.d. (l‐DOPA)

n.d. (l‐tyrosine)

40

His333Asn‐(HisB3)

n.d. (l‐DOPA)

n.d. (l‐tyrosine)

40

SgTYR

His37Gln‐(HisA1)

−12500‐fold (l‐DOPA: ∼0.2 units/mg)

n.i.

55

[57]

His53Gln‐(HisA2)

−12500‐fold (l‐DOPA: ∼0.2 units/mg)

n.i.

45

His62Asn‐(HisA3)

−12500‐fold (l‐DOPA: ∼0.2 units/mg)

n.i.

55

His189Asn‐(HisB1)

−12500‐fold (l‐DOPA: ∼0.2 units/mg)

n.i.

90

His193Gln‐(HisB2)

−6250‐fold (l‐DOPA: 0.4 units/mg)

n.i.

50

His215Gln‐(HisB3)

−2778‐fold (l‐DOPA: 0.9 units/mg)

n.i.

85

ScTYR

His63Phe‐(HisA3)

n.i.

n.d. (l‐tyrosine)

n.i.

[47]

[a] Refers to AoTYR (mel0‐Q00234). n.d.: no detected activity, n.i.: no information from the particular study, entries in μmol/(l×min) refer to volumetric activity, s‐1 to kcat values, and units/mg to specific enzymatic activity. One unit of enzymatic activity is defined as that amount of enzyme that catalyzes the formation of one μmol of product (ortho‐quinone) per minute under reaction conditions optimized for quickest conversion of the respective educt.